2-naphthol has been researched along with hs 1793 in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 14 (77.78) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, HY; Chung, SW; Ha, YM; Lee, H; Song, S; Suh, H | 1 |
| Jeong, SH; Jo, WS; Kwon, TK; Leem, SH; Seol, SY; Song, S; Suh, H; Yoo, YH | 1 |
| Jeong, NY; Jeong, SH; Kim, TH; Kwon, TK; Lee, JS; Park, BS; Song, S; Suh, H; Yoo, KS; Yoo, YH | 1 |
| Bae, JH; Jeong, NY; Kwon, TK; Park, JW; Suh, H; Um, HJ; Yoo, YH | 1 |
| Choi, YH; Jeong, NY; Lee, JS; Lee, SY; Rho, JH; Song, S; Suh, H; Yoo, KS; Yoo, YH; Yoon, YG | 1 |
| Choi, YJ; Jeong, MH; Jo, WS; Kim, SD; Lee, CM; Lee, SH; Ryu, SR; Seo, SY; Suh, Hs; Yang, KM; Yoo, YH | 1 |
| Choi, YJ; Jeong, MH; Jo, WS; Kim, HJ; Park, YS; Son, CH; Suh, HS; Yang, KM; Yun, JH | 1 |
| Han, J; Jeong, SH; Kim, HK; Kim, N; Ko, KS; Lee, SR; Rhee, BD; Song, IS; Song, S; Suh, H; Yoo, YH; Yoon, YG | 1 |
| Han, J; Hanh, TM; Jeong, SH; Kim, HK; Kim, N; Ko, KS; Lee, SR; Noh, SJ; Rhee, BD; Song, IS; Song, S; Suh, H | 1 |
| Choi, YH; Chung, HY; Hossain, MA; Kim, DH; Kim, GY; Kim, JA; Kim, MY; Kim, ND; Suh, HS; Yoon, JH | 1 |
| Chung, HY; Hossain, MA; Jeong, TC; Kim, DH; Kim, JA; Kim, MY; Kim, ND; Suh, H; Sung, B; Yoon, JH | 1 |
| Jeong, DH; Jeong, MH; Jeong, SK; Jo, WS; Jo, YR; Lee, CG; Lee, KW; Oh, SJ; Yang, KM | 1 |
| Choi, YJ; Jeong, MH; Jeong, SK; Jo, WS; Lee, CW; Lee, KY; Oh, SJ; Park, YS; Yang, K | 1 |
| Choi, YJ; Heo, K; Jeong, MH; Park, HS; Yang, KM | 1 |
| Chung, HY; Jung, JH; Kim, DH; Kim, MJ; Kim, ND; Suh, H; Sung, B | 1 |
| Choi, YH; Chung, HY; Hwang, NL; Hwang, SY; Im, E; Kang, YJ; Kim, DH; Kim, JA; Kim, ND; Suh, H; Sung, B | 1 |
| Ha, NC; Han, J; Jang, SW; Jeong, SH; Jeong, YJ; Kim, HK; Ko, KS; Rhee, BD; Shim, S; Shin, M; Song, IS | 1 |
| Jeong, MH; Jeong, SK; Jo, WS; Kang, YR; Kim, JS; Lee, CG; Oh, SJ | 1 |
18 other study(ies) available for 2-naphthol and hs 1793
| Article | Year |
|---|---|
4-(6-Hydroxy-2-naphthyl)-1,3-bezendiol: a potent, new tyrosinase inhibitor.
Topics: Agaricales; Animals; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydroquinones; Kinetics; Melanins; Melanoma, Experimental; Mice; Monophenol Monooxygenase; Naphthalenes; Naphthols; Phenols; Pyrones; Resorcinols; Resveratrol; Stilbenes | 2007 |
A novel resveratrol derivative, HS1793, overcomes the resistance conferred by Bcl-2 in human leukemic U937 cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Nucleus; Cell Survival; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Immunoprecipitation; Membrane Potential, Mitochondrial; Methylation; Mitochondria; Molecular Structure; Naphthols; Proto-Oncogene Proteins c-bcl-2; Resorcinols; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; U937 Cells | 2009 |
A novel resveratrol analogue HS-1793 treatment overcomes the resistance conferred by Bcl-2 and is associated with the formation of mature PML nuclear bodies in renal clear cell carcinoma Caki-1 cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique; Humans; Intranuclear Inclusion Bodies; Kidney Neoplasms; Leukemia, Promyelocytic, Acute; Membrane Potential, Mitochondrial; Microscopy, Confocal; Naphthols; Nuclear Proteins; Promyelocytic Leukemia Protein; Proto-Oncogene Proteins c-bcl-2; Resorcinols; Resveratrol; Stilbenes; Transcription Factors; Tumor Suppressor Proteins | 2009 |
Differential effects of resveratrol and novel resveratrol derivative, HS-1793, on endoplasmic reticulum stress-mediated apoptosis and Akt inactivation.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Calcium; Caspase Inhibitors; Caspases, Initiator; Cell Proliferation; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Enzyme Activation; Heat-Shock Proteins; HT29 Cells; Humans; Naphthols; Phosphorylation; Proto-Oncogene Proteins c-akt; Regulatory Factor X Transcription Factors; Resorcinols; Resveratrol; RNA Splicing; RNA, Messenger; Signal Transduction; Stilbenes; Stress, Physiological; Transcription Factor CHOP; Transcription Factors; X-Box Binding Protein 1 | 2010 |
The novel resveratrol analog HS-1793-induced polyploid LNCaP prostate cancer cells are vulnerable to downregulation of Bcl-xL.
Topics: Antineoplastic Agents; Apoptosis; Aurora Kinase B; Aurora Kinases; bcl-X Protein; Cell Line, Tumor; Cell Survival; Down-Regulation; Drug Synergism; HCT116 Cells; Humans; K562 Cells; Male; Naphthols; Polyploidy; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Resorcinols; U937 Cells | 2011 |
Resveratrol analog, HS-1793 enhance anti-tumor immunity by reducing the CD4+CD25+ regulatory T cells in FM3A tumor bearing mice.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Female; Mice; Mice, Inbred C3H; Naphthols; Neoplasms; Resorcinols; Spleen; T-Lymphocytes; Tumor Burden | 2012 |
The novel resveratrol analogue HS-1793 induces apoptosis via the mitochondrial pathway in murine breast cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 3; Cell Line, Tumor; Cell Survival; Cytochromes c; Female; G1 Phase; Membrane Potential, Mitochondrial; Mice; Mitochondria; Naphthols; Poly(ADP-ribose) Polymerases; Resorcinols; Signal Transduction | 2012 |
An analogue of resveratrol HS-1793 exhibits anticancer activity against MCF-7 cells via inhibition of mitochondrial biogenesis gene expression.
Topics: Antineoplastic Agents; Caspases; Cell Survival; Down-Regulation; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Mitochondrial Proteins; Mitochondrial Turnover; Naphthols; Oxidative Phosphorylation; Resorcinols; Resveratrol; Stilbenes | 2012 |
HS-1793, a recently developed resveratrol analogue protects rat heart against hypoxia/reoxygenation injury via attenuating mitochondrial damage.
Topics: Animals; Calcium; Heart; Hypoxia; Mitochondria; Myocardial Reperfusion Injury; Naphthols; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resorcinols; Resveratrol; Stilbenes | 2013 |
A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1α and VEGF expression, and migration in human prostate cancer cells.
Topics: Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cell Survival; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Naphthols; Neovascularization, Pathologic; Prostatic Neoplasms; Resorcinols; Signal Transduction; Vascular Endothelial Growth Factor A | 2013 |
HS-1793, a resveratrol analogue, induces cell cycle arrest and apoptotic cell death in human breast cancer cells.
Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Breast Neoplasms; Caspases; Cell Cycle Checkpoints; Cell Proliferation; Female; Flow Cytometry; Humans; Immunoprecipitation; Naphthols; Resorcinols; Tumor Cells, Cultured | 2014 |
Protective activity of a novel resveratrol analogue, HS-1793, against DNA damage in 137Cs-irradiated CHO-K1 cells.
Topics: Animals; Cell Survival; Cesium Radioisotopes; CHO Cells; Cricetinae; Cricetulus; DNA Damage; Dose-Response Relationship, Drug; Naphthols; Radiation Dosage; Radiation Tolerance; Radiation-Protective Agents; Resorcinols | 2014 |
Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages.
Topics: Animals; Cell Line, Tumor; Cell Movement; Female; Interferon-gamma; Macrophages; Mice; Mice, Inbred C3H; Naphthols; Neoplasm Invasiveness; Neoplasms; Resorcinols; Resveratrol; Stilbenes | 2014 |
The resveratrol analog HS-1793 enhances radiosensitivity of mouse-derived breast cancer cells under hypoxic conditions.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Movement; Cell Survival; Enzyme-Linked Immunosorbent Assay; Female; Hypoxia; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Microscopy, Fluorescence; Naphthols; Neoplastic Stem Cells; Neovascularization, Pathologic; Radiation Tolerance; Radiation-Sensitizing Agents; Real-Time Polymerase Chain Reaction; Resorcinols; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2016 |
Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Chromones; Colonic Neoplasms; Cytochromes c; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; HCT116 Cells; Humans; Morpholines; Naphthols; Phosphorylation; Proto-Oncogene Proteins c-akt; Resorcinols; Resveratrol; Stilbenes | 2017 |
HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model.
Topics: Animals; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; MCF-7 Cells; Mice; Naphthols; Resorcinols; Triple Negative Breast Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2017 |
Pharmacologic inhibition of AKT leads to cell death in relapsed multiple myeloma.
Topics: Aged; Animals; Apoptosis; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; HSP90 Heat-Shock Proteins; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Multiple Myeloma; Naphthols; Neoplasm Recurrence, Local; NF-kappa B; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Resorcinols; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
The resveratrol analogue, HS‑1793, enhances the effects of radiation therapy through the induction of anti‑tumor immunity in mammary tumor growth.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemoradiotherapy; Concanavalin A; Female; Interleukin-10; Mammary Neoplasms, Experimental; Mice; Naphthols; Radiation-Sensitizing Agents; Resorcinols; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Treatment Outcome; Xenograft Model Antitumor Assays | 2020 |